Aurobindo, AstraZeneca ink supply pact

07 Sep 2010 Evaluate

Aurobindo Pharma, has signed a deal with the UK-based AstraZeneca to supply a range of generic drugs. Aurobindo will supply 25 solid dosage and sterile products to be sold in 40 emerging markets, excluding India and China. These products will address therapeutic segments such as anti-infective, cardiovascular system and central nervous system. 

The deal is the second such agreement for the Hyderabad-based drug maker in the past two years. A similar one with US giant Pfizer was signed in March last year. Together, the two deals are expected to produce $350-$500-million revenue next year.

crackcrack

Aurobindo Pharma Share Price

1191.15 8.65 (0.73%)
06-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1694.70
Dr. Reddys Lab 1241.15
Cipla 1330.80
Zydus Lifesciences 887.85
Lupin 2168.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×